Device Trial Radar · NCT01240330
Vasculaire Compression System Increases Flow Velocity in the Femoral Vein
Last checked: Nov 19, 2026Latest source record: Mar 3, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
33
Actual
Start
Aug 2010
Primary completion
Sep 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- Venous Health Systems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 15, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this clinical study was to demonstrate the performance of the Vasculaire Compression System to increase femoral venous peak velocity (PFV) in healthy subjects. This study was a single-arm, open label, prospective, single-center clinical study.
Conditions
- Venous Thrombosis
Interventions
Pneumatic Compression therapyDevice
Subject comparison analysis of femoral venous Peak Flow Velocity at rest and during compression therapy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Femoral Venous Peak Flow Velocity Compared to Resting BaselineTime frame: 3 measurements/10 min. therapy
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Venous Health System, Inc.
Portola Valley, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.